Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Academic origin
- Ownership
- Private
- Development stage
- Other
01
Overview
Academic Origin is a biotechnology company focused on bridging the gap between academic research and commercial drug development. The company identifies high-potential therapeutic candidates within university settings and provides the necessary resources, expertise, and funding to advance them through the pre-clinical stage. Their current portfolio includes early-stage programs in oncology and infectious diseases, utilizing both small molecule and peptide modalities. By streamlining the translation of basic science into clinical assets, Academic Origin aims to accelerate the delivery of innovative treatments to patients.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Beyond the preview
Go deeper on Academic origin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Academic origin.